Authors: El Kasmi, KC Muller, CP

Citation: Kc. El Kasmi et Cp. Muller, New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules, VACCINE, 19(17-19), 2001, pp. 2238-2244

Authors: El Kasmi, KC Fillon, S Theisen, DM Hartter, H Brons, NHC Muller, CP

Citation: Kc. El Kasmi et al., Neutralization of measles virus wild-type isolates after immunization witha synthetic peptide vaccine which is not recognized by neutralizing passive antibodies, J GEN VIROL, 81, 2000, pp. 729-735

Authors: El Kasmi, KC Deroo, S Theisen, DM Brons, NHC Muller, CP

Citation: Kc. El Kasmi et al., Crossreactivity of mimotopes and peptide homologues of a sequential epitope with a monoclonal antibody does not predict crossreactive immunogenicity, VACCINE, 18(3-4), 1999, pp. 284-290

Authors: El Kasmi, KC Theisen, D Brons, NHC Ammerlaan, W Klingele, M Truong, AT Muller, CP

Citation: Kc. El Kasmi et al., A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis, VACCINE, 17(19), 1999, pp. 2436-2445

Authors: El Kasmi, KC Theisen, D Brons, NHC Muller, CP

Citation: Kc. El Kasmi et al., The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein, MOL IMMUNOL, 35(14-15), 1998, pp. 905-918